載入...
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Natalizumab, a humanized anti-α4 integrin monoclonal antibody, is a highly effective treatment approved for MS. An association between MS and an exposure to Epstein-Barr Virus (EBV) sustained by the l...
Na minha lista:
| 發表在: | Dis Markers |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4460255/ https://ncbi.nlm.nih.gov/pubmed/26101453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/901312 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|